Characterization of the human topoisomerase IIβ (TOP2B) promoter activity : essential roles of the nuclear factor-Y (NF-Y)-and specificity protein-1 (Sp1)-binding sites
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Eukaryotic topoisomerase II (topo II) catalyses topological genomic changes essential for chromosome segregation, chromatin reorganization, DNA replication and transcription. Mammalian topo II exists as two isoforms, designated α and β. Human topo IIα is an important cancer drug target, and an established determinant of drug sensitivity and resistance. Human topo IIβ is also the target of anticancer drugs but its role in drug resistance is less clear. The two human topo II proteins are encoded by the TOP2A and TOP2B genes, respectively, which despite their highly conserved structural organization, are subject to distinctly different modes of regulation. In the present study, we have cloned and characterized the human TOP2B promoter containing a 1.3 kb fragment of the 5h-flanking and untranslated region (k1067 to j193). We found that the promoter activity of this TOP2B fragment was constant throughout the cell cycle, in contrast to the activity of the proximal promoter of TOP2A which was low in resting cells and enhanced during proliferation.
INTRODUCTION
DNA topoisomerase II (topo II ; human gene symbol TOP2) is a nuclear enzyme that alters the topology of DNA. It is essential for a number of nuclear processes, including chromosome condensation, chromatid separation and relief of torsional stress that occurs during DNA replication and transcription (reviewed in [1] ). Two isoforms of the mammalian enzyme exist, designated topo IIα and topo IIβ, that are encoded by the TOP2A and TOP2B genes located on chromosomes 17q21-22 and 3p24, respectively [2] [3] [4] . The high degree of sequence similarity and conservation of the intron\exon organization of the two genes indicates that they have most likely arisen by duplication of an ancestral gene [5] . The two isoforms share similar catalytic properties [6] , but the regulation of their activities and patterns of expression in normal tissues are distinctly different. For example, topo IIα expression is tightly regulated in a cell-cycleand proliferation-dependent manner [7, 8] , and is believed to play a critical role in mitosis [8, 9] . In contrast, topo IIβ expression is relatively independent of growth status and the cell cycle [7, 10] and its cellular function is less certain. In i o, topo IIα is expressed predominantly in proliferating compartments of tissues whereas topo IIβ is more widely expressed in both proliferating and differentiated tissues [11, 12] . Although cell lines lacking topo IIβ expression can be established [13] [14] [15] , mice with targeted disruption of TOP2B fail to develop appropriate neural innervation of skeletal muscle and die shortly after birth due to a Abbreviations used : DOTAP/DOPE, N- [1-(2,3-dioleoyloxy) propyl]-N,N,N-trimethylammonium methylsulphate/dioleoyl phosphatidylethanolamine ; GMSA, gel mobility-shift assay ; ICB, inverted CCAAT box ; NF-Y, nuclear factor-Y ; Sp1, specificity protein-1 ; SV, simian virus ; topo II, topoisomerase II. 1 To whom correspondence should be addressed (e-mail coles!post.queensu.ca).
Analyses of 5h-serially and internally deleted luciferase reporter constructs revealed that 80 % of the TOP2B promoter activity could be attributed to the region between k533 and k481. Mutational analyses of putative regulatory elements indicated that two inverted CCAAT boxes (ICBs) within this region were essential for TOP2B promoter activity and gel mobility-shift assays indicated these sites bound the transcription factor nuclear factor-Y (NF-Y). Co-transfection experiments using a dominantnegative form of subunit A of NF-Y suggested that TOP2B promoter activity required direct interaction of NF-Y with the ICBs. In addition, a specificity protein-1 (Sp1)-binding GC box located just upstream of the ICBs was shown to contribute to TOP2B promoter activity in a synergistic manner with the ICBs. Our results suggest that the binding sites for NF-Y and Sp1 are critical for TOP2B transcription.
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breathing impairment, suggesting that this isoform is essential for mammalian neural development [16] . Topo IIα is a well-characterized determinant of drug sensitivity [17, 18] and is known to be the cellular target for several widely used anticancer drugs whose mechanism of action involves either inhibition of the enzyme's catalytic activities or stabilization of topo II-DNA cleavable complexes that leads to DNA damage [17] . Unfortunately, resistance often emerges after exposure of tumour cells to topo II-targeting drugs or is inherently present depending on the type of tumour. Mechanisms of drug resistance involving topo IIα include altered enzyme activity, aberrant localization of the enzyme to the nucleus and reduced levels of protein expression, all of which result in decreased DNA damage in tumour cells exposed to topo II-targeting drugs [15, [18] [19] [20] . Numerous studies of the regulatory mechanisms governing TOP2A gene expression have provided insight as to how this gene may be down-regulated in drug resistance as well as furthering our understanding of the biological function(s) of this isoenzyme [18, 21] .
Topo IIβ is also known to be a drug target, and several selective inhibitors have been described [22] . Moreover, there is some evidence that reduced topo IIβ expression is associated with the development of drug resistance [13, 14, 22, 23] . However, in contrast to topo IIα, little is known about the regulatory mechanisms governing expression of this enzyme. As an initial step towards understanding the factors controlling the expression of TOP2B, we have isolated a 1.3 kb genomic fragment corresponding to the 5h-flanking and untranslated regions of TOP2B and investigated some of the functional elements and transcription factors involved in the ability of this region to drive expression of a reporter gene in transfected cells. Our data indicate that two inverted CCAAT boxes (ICBs), which bind the nuclear factor-Y (NF-Y) transcription factor, and a GC box, which binds the specificity protein-1 (Sp1) transcription factor, are important for TOP2B promoter activity.
MATERIALS AND METHODS

Cell culture and reagents
HeLa cells and NIH3T3 cells were cultured in Dulbecco's modified Eagle's medium with 10 % fetal bovine serum. Monoclonal antibodies against NF-YA (sc-7712) and polyclonal antiserum against Sp1 (sc-59) were products of Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). Wild-type NF-YA and dominant-negative mutant NF-YA cDNA expression vectors were kindly provided by Dr Roberto Mantovani (University of Modenae Reggio, Milano, Italy). Oligonucleotides were synthesized by Cortec (Kingston, Ontario, Canada) or by ACGT Corporation (Toronto, Ontario, Canada).
Cloning of the 5h-flanking and untranslated regions of TOP2B and construction of reporter plasmids
TOP2B genomic clones (109D5 and 263H17) were isolated by screening a human BAC library using a probe derived from TOP2B cDNA (j72 to j1370 of the coding sequence) by the Canadian Institutes of Health Research Genome Research Facility (Hospital for Sick Children, Toronto, Ontario, Canada). Positive clones were digested with HindIII and subcloned into the pcDNA3.1(k)2 vector (Promega, Madison, WI, U.S.A.) to create pcDNA3.1(k)-TOP2B. The resulting clones were further screened with a $#P-labelled oligonucleotide probe derived from TOP2B exon 1 (5h-CCGGGGACCAGCCACTTACCACCC-AGG-3h) using standard filter-hybridization techniques [24] . One of the positive clones isolated contained a 4.3 kb fragment that was determined to include a 1.3 kb sequence upstream of the translation-initiation site. A 1.4 kb HindIII\EcoRI fragment from this clone containing the entire 5h-flanking sequence, the first exon and part of the first intron of TOP2B was inserted into pGEM3Z2 (Promega) to create pGEM3Z-TOP2B for further subcloning purposes.
The TOP2B luciferase reporter plasmids were constructed by subcloning the TOP2B sequence k1067 to j193 (where j1 denotes the major transcription start site) [25] from pcDNA3.1(k)-TOP2B into the HindIII\NcoI sites of the pGL3-Basic luciferase vector (Promega) to create k1067TOP2B-pGL3. Various 5h-serially deleted TOP2B luciferase constructs (see Figure 1 and Figure 3A below) were prepared by standard PCR cloning techniques. PCR-amplified products spanning progressively shorter regions of TOP2B promoter and all ending at j193 were prepared using the appropriate KpnI-tagged forward primers with the NcoI-containing reverse primer (j193 ; 5h-TGGCGTCTTCCATGGCGAGTGCCTCC-3h ; NcoI site in italics) and k1067TOP2B-pGL3 as template. The resulting amplified fragments were then subcloned into the KpnI and NcoI sites of pGL3-Basic. Additional luciferase constructs with 5h-ends at positions k385, k125 and k37 were prepared by restriction-enzyme digestion of the k1067TOP2B-pGL3 construct and subsequent re-ligation of blunt-ended DNA as follows : k385TOP2B-pGL3, HindIII\BstEII ; k125TOP2B-pGL3, HindIII\PstI ; and k37TOP2B-pGL3, HindIII\XmaI.
The internally deleted constructs ∆1-TOP2B, ∆2-TOP2B and ∆3-TOP2B (see Figure 3C below) were prepared by first removing the BbsI\PpuMI, PpuMI\NotI and NotI\BstEII fragments, respectively, from pGEM3Z-TOP2B by restriction digestion followed by recircularization. The HindIII (k1067)\NcoI (j193) fragments from the resulting plasmids were then transferred into pGL3-Basic. The ∆4-TOP2B reporter construct was prepared by subcloning a BstEII-tagged PCR fragment from k309 to j193 (NcoI) into a BstEII\NcoI digested vector fragment of k1067TOP2B-pGL3. The ∆5-TOP2B and ∆6-TOP2B constructs were prepared by removing PstI-digested or SmaI-digested fragments, respectively, from k1067TOP2B-pGL3 followed by recircularization.
Mutations of several potential regulatory elements (see Figure 4 below) were introduced into the k1067TOP2B-pGL3 reporter construct by PCR using the oligonucleotides listed in Table 1 . Briefly, two individual amplification reactions were performed on the wild-type k1067TOP2B-pGL3 template using the following primers that have restriction sites introduced into the mutated elements (Table 1 ) and primers flanking the elements k1067 (5h-CTATCGATAGGTACCAAGCTT TTC-ATA-3h, HindIII site in italics) and k385 (5h-GCCGCCA-CGGTCACCTCCCTCTTGTCC-3h, BstEII site in italics) to facilitate identification of mutants and subcloning. The two PCR fragments obtained were digested with the appropriate restriction enzymes and subcloned into the HindIII and BstEII sites of k1067TOP2B-pGL3.
For construction of the TOP2A promoter reporter plasmid 620TOP2A-pGL3, a TOP2A fragment (k620 to j90) was isolated from genomic DNA from human peripheral blood mononuclear cells by PCR using the primer pairs, 5h-GGGG-TACC TCCAGCCACCGCACACAGCCTA-3h [k620 ; tagged with a KpnI-recognition site (italics)] and 5h-GAAGATCTGGT-GACGGTCGTGAAGGGGCTCA-3h [j90 ; tagged with a BglII-recognition site (italics)]. The resulting amplified fragments were then subcloned into the KpnI and BglII sites, respectively, of pGL3-Basic. The fidelity of all constructs was confirmed by sequencing (Canadian Molecular Research Services, Ottawa, Ontario, Canada).
Transfections, reporter assays and flow cytometry
HeLa cells were seeded at 1i10& cells\well in a 24-well plate the day before transfection with the luciferase reporter plasmids. For each transfection, a total of 0.3 µg of plasmid DNA was mixed with 2 µg of N- [1-(2,3- 
.).
Renilla luciferase internal control expression plasmids (10-30 ng of pRL-TK, pRL-CMV or pRL-SV40 ; Promega) were also cotransfected as indicated in the figure legends. Unless otherwise stated, the activities of pRL internal control plasmids chosen for particular experiments were not affected by co-transfection or post-transfection treatment and hence mainly reflect variations in transfection efficiencies or cell harvesting between samples.
Table 1 Oligonucleotides used for gel mobility-shift assays and mutagenesis of putative regulatory elements in the TOP2B promoter
Putative regulatory elements are shown in bold. The mutated nucleotides are underlined and the resulting restriction sites used for facilitating subcloning are indicated. Shown are the upper strands of the oligonucleotides.
Oligonucleotide
Sequence Position Restriction site introduced TOP2B ICB1 5h-ACA AGG CCC GGA TTG GAC AGC ATG GCG-3h k501 to k475 TOP2B mICB1 5h-ACA AGG CCC GTC TAG AAC AGC ATG GCG-3h XbaI TOP2B ICB2 5h-GGA ATT TTG GGA TTG GCC GAG AGG CTG-3h k533 to k507 TOP2B mICB2 5h-GGA ATT TTG GAG ATC TCC GAG AGG CTG-3h Bgl II MHC Y (prototypical CCAAT box) 5h-ATA TTT TTC TGA TTG GCC AAA GAG TAA-3h TOP2B GC 5h-CTC GGG TCC CGC CCC TCC AGG-3h k 561 to k541 TOP2B mGC 5h-CTC GGG TCG AGC TCC TCC AGG-3h
Luciferase activities were determined using the Dual-Luciferase2 Reporter Assay System according to the manufacturer's instructions (Promega) using a MicroLumat Plus2 microplate luminometer (EG & G Berthold, Bad Wildbad, Germany). Results are reported as relative luciferase units.
To follow the effect of cell proliferation on TOP2B and TOP2A promoter activities, NIH3T3 cells were seeded at 1i10& cells\well in 24-well plates and cells transfected the following day with 300 ng of k620TOP2A-pGL3 or k1067TOP2B-pGL3 together with 10 ng of pRL-CMV using DOTAP\DOPE liposomes as before. After 24 h, cells were growth-arrested by serum starvation in medium containing 0.5 % serum for 48 h. Cells were then stimulated to proliferate by replacing the medium with medium containing 10 % serum. At the specified time periods, cells were harvested and luciferase activities measured as before. For estimation of cell-cycle distribution, cells were set up in parallel in 25 cm# tissue-culture flasks, subjected to the same growth-arrest\re-stimulation treatments and harvested at specified intervals for nuclear staining with propidium iodide. Samples were assayed with an EPICS2 ALTRA TM flow cytometer (488 nm excitation wavelength, 595 nm emission wavelength) and the data analysed with Expo32 TM software (Beckman Coulter, Mississauga, Ontario, Canada).
Gel mobility-shift assays (GMSAs)
Extracts of nuclear proteins were prepared from cells by salt extraction of isolated nuclei to a final protein concentration of 2 µg\µl as described in [26] . Oligonucleotides were 5h-end-labelled with [γ-$#P]ATP using T4 DNA kinase to a specific activity of 500-1000 c.p.m.\fmol and annealed with a 2-fold excess of complementary oligonucleotides. DNA-protein binding reactions (20 µl) containing 10 mM Tris\HCl (pH 7.8), 1 mM EDTA, 0.1 mM dithiothreitol, 5 % glycerol, 1 µg of poly(dIdC) : poly(dI-dC) and 5-10 µg of nuclear extract protein were incubated at room temperature for 10 min. $#P-Labelled oligonucleotides (20 fmol) were then added to each reaction for a further 30 min. For competition or supershift GMSAs, a 100-fold excess of unlabelled competitor oligonucleotide or 1 µg of the appropriate antisera were preincubated with the nuclear extracts for 15 min at room temperature before adding the $#P-labelled probes. The DNA-protein complexes were resolved on 6 % polyacrylamide gels in 0.25iTris\borate\EDTA buffer and then exposed to Kodak X-ray film at k70 mC.
Immunoblot analysis
Expression levels of wild-type and dominant-negative NF-YA in transfected HeLa cells were determined by immunoblot analysis. Transfected cells were washed and whole-cell lysates prepared in buffer containing 20 mM Hepes, 450 mM NaC1, 0.5 mM EDTA, 25 % glycerol and 0.5 mM PMSF. Protein extracts (10 µg) were resolved by 10 % polyacrylamide gel and transferred to a nylon membrane. Blots were incubated with a monoclonal antibody against NF-YA and antibody binding detected with horseradish peroxidase-conjugated goat antimouse secondary antibody, followed by chemiluminescence detection (Perkin Elmer Life Sciences).
RESULTS
Isolation of the human TOP2B promoter
A genomic TOP2B clone isolated from a human BAC library was shown to contain 5h-untranslated and flanking regions of TOP2B extending more than 1.3 kb upstream of the translational initiation start codon (Figure 1 ). Sequencing of this 5h region showed that it bears minimal sequence similarity with the human TOP2A promoter but, like TOP2A, lacks a TATA box [25, 27] . The TOP2B promoter is very GC-rich with a 90 % GC content in the proximal promoter and 5h-untranslated region. This region also has a high number of clustered CpG or GpC dinucleotides with features characteristic of a CpG island. In addition, two short dinucleotide repeats, (GT) & at k420 and (GT) ' at k338, and one short trinucleotide repeat, (GGC) ' at k377, were identified. The entire isolated sequence (k1067 to j193) is in exact agreement with a human genomic clone deposited in GenBank under accession no. AC093416. It is also identical to a short TOP2B proximal promoter sequence (k70 to j193) deposited by Ng et al. [25] (accession no. U65315), except that a CG is noted as GC at j160 to j161.
For initial characterization of TOP2B promoter activity, the 1.3 kb fragment upstream of the start codon (k1067 to j193) was subcloned into a promoterless luciferase reporter plasmid such that it was contiguous with the start codon of the luciferase coding region. This construct was transiently transfected into HeLa cells, and when assayed for luciferase activity was found to possess transcriptional activity comparable with that of control reporter plasmids driven by a simian virus (SV) 40 promoter (pGL3-control).
Comparison of TOP2B and TOP2A promoter activities
The TOP2B promoter activity was then compared with that of the TOP2A promoter, which is known to exhibit a moderate degree of cell-cycle-dependent and proliferation-stimulated transcriptional activity [28, 29] . Thus TOP2A and TOP2B promoter reporter constructs (k620TOP2A-pGL3 and k1067TOP2B-
Figure 1 Sequence of the 5h-flanking and untranslated regions of human TOP2B
The transcriptional start site is denoted as j1 [25] . Putative transcriptional regulatory elements identified in this study are shown in bold, as is the ATG translational start codon. Nucleotide repeats are underlined. pGL3) were transiently transfected into NIH3T3 cells. Transfected cells were then growth-arrested by serum starvation for 48 h followed by re-stimulation of proliferation by re-addition of 10 % serum. Cell lysates were prepared at specified time intervals and luciferase activity measured (Figure 2A) . The cell cycle status of cells subjected to the same serum starvation and replenishment procedures was assessed by flow cytometry ( Figure  2B ). Initial experiments indicated that the transfection procedures used had no effect on the subsequent growth arrest by serum deprivation and proliferation upon serum replenishment. As shown in Figure 2(A) , the activity of the TOP2B promoter construct did not vary appreciably during serum-stimulated proliferation of NIH3T3 cells for 24 h. In contrast, TOP2A promoter activity was relatively low in the first 12 h when the cells were still in resting stage (G ! \G " ) and significantly increased 2-3-fold from 12 to 24 h when the cells entered the active phase of cell growth (SjG # jM), consistent with previous observations using a similar experimental system [28, 29] . To further compare the properties of the TOP2A and TOP2B promoters, the effect of Figure 2 Comparison of TOP2B and TOP2A promoter regulation (A) Effect of serum re-stimulated growth on TOP2B and TOP2A promoter reporter activities. NIH3T3 cells were transfected with reporter constructs of the TOP2A promoter (k620TOP2A-pGL3) or TOP2B (k1067TOP2B-pGL3) together with 10 ng of pRL-CMV as an internal control. Cells were serum-starved for 48 h and then stimulated to proliferate by replacing the medium with medium containing 10 % serum. At the specified time periods, luciferase activities were measured using the dual luciferase assay system. Values shown are meanspS.E.M. from three determinations in a single experiment. Similar results were obtained in a second experiment. RLU, relative luciferase units. (B) Cell-cycle analysis of NIH3T3 cells. Parallel cultures were subjected to the same growth-arrest/re-stimulation treatments and harvested at specified intervals for flow cytometry analysis. The percentages of cells in resting (G 0 jG 1 ) and active growth (SjG 2 jM) phases are indicated.
trichostatin A, a histone deacetylase inhibitor which is known to activate the TOP2A promoter, was also investigated. As demonstrated previously, we found that TOP2A promoter activity was markedly stimulated ( 7-fold) by exposure of cells to trichostatin A [30, 31] . However, the TOP2B promoter reporter construct was stimulated only 2-fold, which is comparable with the increase observed for the internal control reporter plasmid (pRL-CMV ; results not shown). 
Deletion analysis of the TOP2B promoter
A panel of 5h-serially deleted TOP2B reporter constructs generated from k1067TOP2B-pGL3 were then tested in transient transfection assays to determine the minimal sequence necessary to drive luciferase expression ( Figure 3A) . These experiments showed that deletion up to k533 did not appreciably affect TOP2B promoter activity while further deletions resulted in at least a 50 % decrease in activity ( Figure 3B ). These findings suggested that the sequence immediately downstream of k533 contains elements required for maximal TOP2B promoter activity. Reporter constructs with deletions of several internal sequences were generated to further define critical regions in the TOP2B promoter. Deletion of TOP2B sequence between k555 and k456 (∆2-TOP2B) resulted in a 70 % decrease in luciferase activity, consistent with results with the 5h-serially deleted reporter constructs ( Figure 3C) . A 35 % reduction in promoter activity was observed for the ∆6-TOP2B construct which was lacking k125 to k37, a region that has a relatively high GC content. Whether or not this decrease is significant is unknown and requires further investigation. Other internal deletions had either no effect on TOP2B promoter activity or decreased it by less than 20 %.
Mutational analysis of GC box and ICBs
Computer-assisted analyses of the region between k555 and k456, shown to be critical for TOP2B promoter activity, were carried out using the TRANSFAC database and MatInspector search program (http:\\transfac.gbf.de\TRANSFAC). These analyses identified multiple putative regulatory elements, including a GC box (Sp1-binding site) at k553 as well as two ICBs, ICB1 and ICB2, at k522 and k490, respectively (Figures 1  and 4) . CCAAT boxes are cis-acting elements recognized by transcription factors such as NF-Y, CCAAT transcription factor\nuclear factor-1 (CTF\NF-1) and CCAAT\enhancer-binding protein (C\EBP) [32] , whereas GC boxes are potential binding sites for members of the Sp family of transcription factors [33] . To determine whether these sequences contributed to TOP2B promoter activity, mutations were introduced into the wild-type k1067TOP2B-pGL3 construct to generate mutants with specific disruption of the respective elements (Table  1 and Figure 4 ). The resulting constructs were then transiently transfected into HeLa cells and dual luciferase activities measured as before. As shown in Figure 4 , one of the most striking changes resulted from mutations of both ICB1 and ICB2 (m[ICB1.ICB2]). This double mutation reduced TOP2B promoter luciferase activity by 70-80 %. In contrast, a single mutation of either the
Figure 6 GMSAs of the ICBs in the TOP2B promoter
HeLa cell nuclear extracts (5 µg) and the indicated 32 P-labelled oligonucleotides or PCR-derived probe (TOP2B k533 to k475 ; 20 fmol) were incubated in a reaction volume of 20 µl at room temperature and then resolved on a 6 % polyacrylamide gel. Oligonucleotide sequences are shown in Table 1 ICB1 or the ICB2 site did not appreciably affect k1067TOP2B-pGL3 activity. These findings suggest that each ICB is sufficient on its own to support TOP2B promoter activity.
Mutation of the GC box at k553 (Figure 4 ) or elimination of this site, as in the k533TOP2B-pGL3 construct ( Figure 3B ), led to a modest ( 20 %) decrease in luciferase activity. However, when the GC box was mutated together with one or other of the ICBs, a much more pronounced decrease in luciferase activity was observed. Thus simultaneous mutation of the GC box and the proximal ICB (m[GC.ICB2]) caused a 50 % decrease in promoter activity (Figure 4) , similar to the decrease observed with the k498TOP2B-pGL3 5h-deletion construct in which both the GC box and ICB2 site are eliminated ( Figure 3B 
DNA-protein binding activities at the ICBs and GC box
To determine whether the ICB1, ICB2 and GC box in the TOP2B promoter are capable of protein binding, GMSAs were performed with HeLa cell nuclear extracts. As shown in Figure  5 (A), an oligonucleotide (k561 to k541) containing the putative GC box of the TOP2B promoter sequence bound proteins with mobilities similar to those bound to an oligonucleotide containing a consensus Sp1 sequence. These binding complexes could be competed with by a 100-fold excess of unlabelled Sp1-binding sequence oligonucleotide but not by an excess of oligonucleotides harbouring a mutated Sp1 sequence (TOP2B mGC ; Table 1 ), which was shown to be defective in protein binding ( Figure 5B) . Furthermore, the major complex was completely supershifted by an Sp1-specific antiserum ( Figure 5C ). Thus the GC box of the TOP2B promoter appears to be a binding site for Sp1.
The ICBs at k522 and k490 were investigated in a similar fashion. As shown in Figure 6 (A), shifted complexes were detected using oligonucleotides corresponding to sequence containing the putative ICB1 (k501 to k475) or ICB2 (k533 to k507) as the labelled probes and the electrophoretic mobilities were similar to those detected using a prototypical CCAAT box sequence, the Y-box found in the MHC class II (MHC II) promoter [34] . These complexes could also be effectively abolished by a 100-fold excess of unlabelled oligonucleotides of the same sequence. However, they were not affected by an excess of unlabelled oligonucleotides containing a mutated CCAAT motif (TOP2B mICB1 or TOP2B mICB2 ; Table 1 ), which showed significantly less binding activity ( Figure 6B ). These observations indicate that the ICB sequences are the specific motif conferring the nuclear protein-binding activities. In addition, the complexes detected could be competed by a 100-fold excess of oligonucleotide corresponding to the MHC Y-box (MHC Y) sequence ( Figure 6A ). Thus the putative ICB1 and ICB2 sequences of TOP2B behave in a fashion similar to the MHC Y-box, which is recognized by the NF-Y transcription factor [34] .
To further characterize the protein-binding activity of the TOP2B ICBs, antiserum raised against subunit A of NF-Y was included in the binding assays. As shown in Figure 6 (C) (lefthand panel), the binding activity at both ICBs of the TOP2B promoter reacted with the anti-NF-YA antibody, but not nonimmune IgG, to form a ' supershifted ' complex in a manner similar to that observed in control reactions with the MHC Y probe. PCR-derived probes corresponding to the TOP2B promoter sequence k533 to k475 containing both ICB1 and ICB2 were also employed in a GMSA. As shown in Figure 6 (C) (righthand panel), binding complexes that reacted with the anti-NF-YA antibody were also detected using this probe. When either ICB1 or ICB2 was mutated (mICB1 or mICB2), the anti-NF-YA antibody still detected binding complexes. However, when both ICBs were disrupted (m[ICB1.ICB2]), no more supershifted activity was detected, indicating that the double mutant is defective for NF-Y binding. The ability of ICB2 to bind NF-Y appears to be somewhat weaker than that of ICB1 ( Figure 6C ), but whether or not this difference is significant requires further investigation.
Effects of expression of dominant-negative NF-YA on TOP2B promoter activity
To further investigate the role of NF-Y on TOP2B promoter activity, a cDNA expression vector encoding a dominantnegative mutant of the A subunit of NF-Y (NF-YA), which renders endogenous NF-Y unable to bind to a CCAAT box [32] , or a cDNA encoding the wild-type NF-YA was co-transfected with wild-type and mutant k1067TOP2B-pGL3 plasmids into HeLa cells and promoter activity assayed 24 h later ( Figure 7 ). Results were expressed relative to the activity observed in independent co-transfections of the empty vector (pSG5) with the k1067TOP2B-pGL3 construct ( Figure 7A ). The results show that ectopic co-expression of dominant-negative NF-YA significantly reduced wild-type k1067TOP2B-pGL3 promoter activity by approx. 40 % whereas co-expression of wild-type NF-YA had no effect. As shown in Figure 7 (B), both the dominantnegative and wild-type NF-YA were expressed in the transfected HeLa cells at comparable levels. To confirm that the effect of dominant-negative NF-YA on TOP2B promoter activity was due to specific inhibition of NF-Y binding to the ICBs, cotransfection experiments were also performed using the k1067TOP2B-pGL3 construct with both ICBs (m[ICB1.ICB2]) disrupted. In these experiments, dominant-negative NF-YA had no effect on the luciferase activity of the mutated TOP2B reporter construct. The dominant-negative NF-YA also had no effect on promoter activity driven by the SV40 promoter, which has no CCAAT box (e.g. pRL-SV40 or pGL3-control), or on the background activity of pGL3-Basic (results not shown).
DISCUSSION
As a first step towards better understanding of the regulation of human topo IIβ expression, we cloned and sequenced the 1.3 kb 5h-flanking region of the TOP2B gene. This TOP2B promoter region is very GC-rich and contains clustered CpG or GpC dinucleotides with features characteristic of a CpG island that represent potential sites for methylation. Several short nucleotide repeats were also identified, but whether or not any of these features play a role in TOP2B gene regulation remains to be determined. Thus these findings add to our previous knowledge of the intron\exon organization of the TOP2B gene [5] and the partial sequence of its promoter [25] .
We next analysed the ability of the TOP2B fragment from k1067 to j193 to drive expression of a luciferase reporter gene. Initially, we compared the properties of the TOP2B promoter with the relatively well characterized TOP2A proximal promoter [27] . In contrast to TOP2A, we found that the TOP2B promoter activity was less dependent on cell-proliferation status. These findings are consistent with previous studies comparing the relative expression levels of the two isozymes. In addition, unlike the TOP2A promoter [31] , the TOP2B promoter was not significantly activated by exposure to an inhibitor of histone deacetylation (C. N. Lok and S. P. C. Cole, unpublished work). These results confirm that a fundamental difference exists between the transcriptional regulation of these two genes.
By deletion analysis, we identified a region in the TOP2B promoter between k533 and k481 that appears responsible for approx. 80 % of promoter activity. By introducing specific mutations into the putative regulatory elements, two ICBs were identified that are critical for TOP2B promoter activity. DNAprotein-binding assays clearly demonstrated that these two putative ICBs bind nuclear factors. CCAAT boxes are found in the regulatory region of 30 % of genes, including those which are so-called housekeeping genes as well as inducible and cell-cycleregulated genes [32] . The role of CCAAT boxes as cis-acting promoter elements depends on their ability to interact with a variety of transcription factors. The most prevalent of these is NF-Y, a ubiquitously expressed heterotrimeric transcription factor composed of three subunits (NF-YA, NF-YB and NF-YC) [32] . All three subunits are necessary for constitution of a functional binding complex to the CCAAT box. Using specific NF-Y antisera in GMSAs, the ICBs of TOP2B were shown to bind NF-Y. Our observations using a dominant-negative form of NF-Y (A subunit) with mutations in the DNA-binding domain, previously demonstrated to abolish the interaction of NF-Y with CCAAT boxes [32] , further confirm that NF-Y interacts with the TOP2B ICBs and is involved in TOP2B promoter activity.
An interesting finding of our study is the loss of TOP2B promoter activity upon simultaneous disruption of the two ICBs while mutation of a single ICB had little effect. These results suggest that each ICB by itself is sufficient to support TOP2B promoter activity. Multiple CCAAT boxes are found in a number of promoters and their spacing is often variable. The centre-tocentre distance between the two ICBs of the TOP2B promoter is 30 bp, which is very close to three multiples of a helical turn of DNA (10.4 bp) [35] . This suggests that protein factors such as NF-Y that bind to the two ICBs are likely to be situated on the same side of the helix and are thus located in very close proximity to one another in the TOP2B promoter. The similar spatial relationships of the DNA-protein interaction at the two ICBs may explain, at least in part, our observation that the two ICBs can be compensatory for one another with respect to their contribution to TOP2B promoter activity when either one is mutated. A similar redundancy of functional ICBs has also been found in the promoter regions of genes encoding human cyclin B1 and cdc25C [36, 37] .
The major protein bound to the TOP2B ICBs was identified as NF-Y. Although extensively studied, the mechanism by which NF-Y regulates gene expression is still not completely understood. However, one widely recognized property of NF-Y is its ability to induce distortion of the double helix upon binding to DNA in itro, thereby influencing the DNA-protein interactions for gene transcription and hence serving as a ' promoter organizer ' [32] . In the TOP2B promoter, the GC box\Sp1 site is located in close proximity to ICB2 and we have shown that Sp1 can bind to this site. We have also shown that mutation of this site, together with the mutation of either one of the ICBs, causes a significant loss of TOP2B promoter activity. These observations suggest that a functional synergy may exist between the ICBs and the GC box in the TOP2B promoter. Such a functional cooperation between NF-Y and Sp1 has previously been shown to be essential for the transcriptional activity of promoters of a number of genes, including the human MHC II-associated invariant chain (Ii) [38] , human and rat fatty acid synthase (FAS) [39] , human cathepsin L [40] and human P-glycoprotein (ABCB1\MDR1) [41] . In all cases, the Sp1-and NF-Y-binding sites are located in close proximity to each other in the promoter regions of these genes. Co-operation may occur in several different ways. Thus it has been demonstrated that NF-Y and Sp1 bind co-operatively to the FAS promoter [39] . In addition, interactions of Sp1 and NF-Y with the p300 co-activator [42, 43] , and a direct physical association of NF-Y and Sp1 [44] , may also explain such co-operativity.
In summary, our results indicate that the binding sites for NF-Y and Sp1 are critical for TOP2B transcription and thus TOP2B expression may be modulated by the levels or activities of these transcription factors. Although NF-Y and Sp factors are considered to be ubiquitously expressed, their levels of expression or activities still vary depending on cell type and stage of cell growth and differentiation [32, 33] , as does TOP2B expression [11, 12] . In this regard, it is of interest that TOP2B mRNA is not detectable in skeletal muscle [11] and NF-Y is not expressed in postmitotic differentiated skeletal muscle cells because of a deficiency of the A subunit [37] . Whether or not a broader correlation exists between the expression of NF-Y (and Sp1) and TOP2B expression in normal and\or malignant cells remains to be determined.
The TOP2A promoter also contains functional ICBs and GC boxes and the regulation of TOP2A promoter activity by these elements is known to be complex. All five ICBs in the TOP2A promoter have been shown to interact with nuclear factors, including NF-Y [28, 30, 45, 46] as well as a novel CCAAT-boxbinding factor, ICBP90 [47] . Interestingly, both stimulatory and repressive roles of the individual ICBs in basal, cell-proliferationdependent, stress-regulated and drug-resistance-associated TOP2A promoter activity have been reported in various cellular backgrounds [28, 30, 46, [48] [49] [50] . CCAAT boxes, through their interaction with NF-Y or other related factors, have also been shown to play a role in the transcriptional regulation of a number of cell-cycle-regulated genes, including TOP2A, that contain a bipartite motif, a so-called cell-cycle-dependent element (CDE) and a cell-cycle genes homology region (CHR) [51] . However, no similar motif is found in the TOP2B promoter. Whether this difference accounts for the differential regulation of TOP2A and TOP2B during cell growth requires further investigation. It is also likely that differences in the organization of the Sp1-and NF-Y-binding sites in these two promoters are important as well [52] . Finally, in view of the functional significance of the ICBs in the regulatory regions of both TOP2 isoforms, it will be of interest to determine whether the emerging class of DNA-binding anticancer compounds that can target CCAAT boxes (or a structurally similar motif ) can affect expression of TOP2A and TOP2B and hence drug sensitivity of malignant cells [53] .
